Literature DB >> 9184595

Local perfusion of diazepam attenuates interictal and ictal events in the bicuculline model of epilepsy in rats.

H G Eder1, D B Jones, R S Fisher.   

Abstract

PURPOSE: We evaluated the efficacy of local perfusion of diazepam (DZP) in suppression of EEG spikes and behavioral seizures produced by bicuculline methiodide (BMI) applied to rat sensory motor cortex and hippocampus.
METHODS: Data were obtained from 37 rats implanted with EEG head plugs and perfusion cannulas. BMI 4 mM, 5 microliters was infused on neocortex through the epidural space in 23 rats. BMI 0.1 mM, 2 microliters was infused into the left hippocampus in 14 rats.
RESULTS: DZP 0.75-1.0 mg markedly reduced the spiking to a level of 9.9 +/- 15.8% of baseline for DZP as compared with 90.2 +/- 57.9% of baseline for vehicle-treated rats. DZP reduced spiking in a hippocampal BMI focus to 1.9 +/- 2.4% of baseline spiking, as compared with 98.0 +/- 95.6% of that in vehicle-treated animals. The amount of spread of solution was estimated with methylene blue (MB) injections. Ictal events also were attenuated. In most of the animals, systemic levels of DZP were unmeasurable and injection on the contralateral side did not reduce spiking.
CONCLUSIONS: These findings suggest that focal application of antiepileptic drugs (AEDs) in brain may be a useful new avenue for therapy of intractable partial seizures.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9184595     DOI: 10.1111/j.1528-1157.1997.tb01134.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  11 in total

1.  Cortical inhibition reduces information redundancy at presentation of communication sounds in the primary auditory cortex.

Authors:  Quentin Gaucher; Chloé Huetz; Boris Gourévitch; Jean-Marc Edeline
Journal:  J Neurosci       Date:  2013-06-26       Impact factor: 6.167

2.  Optical control of focal epilepsy in vivo with caged γ-aminobutyric acid.

Authors:  Xiaofeng Yang; Daniel L Rode; Darcy S Peterka; Rafael Yuste; Steven M Rothman
Journal:  Ann Neurol       Date:  2012-01       Impact factor: 10.422

Review 3.  Therapeutic devices for epilepsy.

Authors:  Robert S Fisher
Journal:  Ann Neurol       Date:  2012-02       Impact factor: 10.422

4.  Local distribution and toxicity of prolonged hippocampal infusion of muscimol.

Authors:  John D Heiss; Stuart Walbridge; Paul Morrison; Robert R Hampton; Susumu Sato; Alexander Vortmeyer; John A Butman; James O'Malley; Param Vidwan; Robert L Dedrick; Edward H Oldfield
Journal:  J Neurosurg       Date:  2005-12       Impact factor: 5.115

Review 5.  New Non-Intravenous Routes for Benzodiazepines in Epilepsy: A Clinician Perspective.

Authors:  Marco Mula
Journal:  CNS Drugs       Date:  2017-01       Impact factor: 5.749

6.  Optical suppression of seizure-like activity with an LED.

Authors:  Steven M Rothman; Gavin Perry; Xiao-Feng Yang; Krzysztof Hyrc; Brigitte F Schmidt
Journal:  Epilepsy Res       Date:  2007-04-19       Impact factor: 3.045

Review 7.  Convection-enhanced delivery in the treatment of epilepsy.

Authors:  Michael A Rogawski
Journal:  Neurotherapeutics       Date:  2009-04       Impact factor: 7.620

Review 8.  Intraventricular and intracerebral delivery of anti-epileptic drugs in the kindling model.

Authors:  Juan A Barcia; José M Gallego
Journal:  Neurotherapeutics       Date:  2009-04       Impact factor: 7.620

Review 9.  Potential new methods for antiepileptic drug delivery.

Authors:  Robert S Fisher; Jet Ho
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

10.  Evolution and prospects for intracranial pharmacotherapy for refractory epilepsies: the subdural hybrid neuroprosthesis.

Authors:  Nandor Ludvig; Geza Medveczky; Jacqueline A French; Chad Carlson; Orrin Devinsky; Ruben I Kuzniecky
Journal:  Epilepsy Res Treat       Date:  2010-02-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.